On March 14, 2026, GoodRx Holdings, Inc. announced a significant change in its auditing firm. The Audit and Risk Committee of the Board of Directors approved the appointment of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026. This decision follows a competitive proposal process aimed at enhancing the company's financial oversight and reporting capabilities. Concurrently, the company has dismissed PricewaterhouseCoopers LLP (PwC) from its role as the independent auditor. The audit reports issued by PwC for the fiscal years ended December 31, 2025, and 2024, did not contain any adverse opinions or disclaimers, indicating that the financial statements were presented fairly in accordance with generally accepted accounting principles. The transition to KPMG is expected to bring fresh perspectives and expertise to GoodRx's financial reporting processes. The company has assured stakeholders that it will maintain transparency throughout this transition and has provided PwC with a copy of the disclosures related to this change. The decision to switch auditors is seen as a proactive measure to ensure robust governance and compliance with regulatory standards, which could positively influence investor confidence and the company's market position moving forward.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.